CLINICAL_TRIALS trial_result · 2020-03-26

Clinical Trial Update: Phase IIb Study of IFN-K in Systemic Lupus Erythematosus [Phase 2]

A Phase IIb trial of IFN-K for systemic lupus erythematosus was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Neovacs | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2020-03-26